NeoGenomics, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
NeoGenomics, Inc. (NEO) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $15.80 million as of 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2023-11-06
- 2023-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $15.80M.
- 2023-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $18.40M.
- 2023-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $12.20M.
- 2022-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $14.80M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2023-09-30 | $15.80M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $18.40M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $12.20M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $14.80M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $13.30M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $12.50M 10-Q · filed 2022-05-09 |
| 2021-09-30 | $14.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $15.00M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $9.00M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $7.30M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $8.80M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $8.20M 10-Q · filed 2020-04-29 |
| 2019-09-30 | $5.70M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $7.40M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $7.50M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $5.10M 10-K · filed 2019-02-26 |
| 2018-09-30 | $3.20M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $4.50M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $7.90M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $5.06M 10-K · filed 2018-03-13 |
| 2017-09-30 | $6.50M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $7.70M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $5.40M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $5.10M 10-K · filed 2017-03-14 |
| 2016-09-30 | $8.20M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $7.40M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $4.00M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $4.86M 10-K · filed 2016-04-18 |
| 2015-09-30 | $3.20M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $3.70M 10-Q · filed 2015-07-31 |
| 2015-03-31 | $900.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $1.20M 10-K · filed 2015-03-03 |
| 2013-12-31 | $654.00K 10-K · filed 2014-02-24 |
| 2012-12-31 | $615.00K 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |